![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RBCK1 |
Gene summary for RBCK1 |
![]() |
Gene information | Species | Human | Gene symbol | RBCK1 | Gene ID | 10616 |
Gene name | RANBP2-type and C3HC4-type zinc finger containing 1 | |
Gene Alias | C20orf18 | |
Cytomap | 20p13 | |
Gene Type | protein-coding | GO ID | GO:0000209 | UniProtAcc | A6PVK0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10616 | RBCK1 | GSM4909286 | Human | Breast | IDC | 4.22e-02 | -2.05e-01 | 0.1081 |
10616 | RBCK1 | GSM4909293 | Human | Breast | IDC | 1.34e-20 | 4.92e-01 | 0.1581 |
10616 | RBCK1 | GSM4909297 | Human | Breast | IDC | 1.16e-03 | -1.17e-01 | 0.1517 |
10616 | RBCK1 | GSM4909311 | Human | Breast | IDC | 1.14e-18 | -4.55e-02 | 0.1534 |
10616 | RBCK1 | GSM4909312 | Human | Breast | IDC | 1.42e-05 | -1.55e-02 | 0.1552 |
10616 | RBCK1 | GSM4909317 | Human | Breast | IDC | 4.12e-15 | 5.58e-01 | 0.1355 |
10616 | RBCK1 | GSM4909318 | Human | Breast | IDC | 1.45e-07 | 5.93e-01 | 0.2031 |
10616 | RBCK1 | GSM4909319 | Human | Breast | IDC | 1.59e-22 | -1.20e-01 | 0.1563 |
10616 | RBCK1 | GSM4909320 | Human | Breast | IDC | 2.73e-04 | -1.08e-01 | 0.1575 |
10616 | RBCK1 | GSM4909321 | Human | Breast | IDC | 2.06e-09 | -3.43e-02 | 0.1559 |
10616 | RBCK1 | brca10 | Human | Breast | Precancer | 2.13e-13 | 5.39e-01 | -0.0029 |
10616 | RBCK1 | NCCBC14 | Human | Breast | DCIS | 2.30e-06 | -1.32e-01 | 0.2021 |
10616 | RBCK1 | NCCBC5 | Human | Breast | DCIS | 3.72e-08 | 3.89e-03 | 0.2046 |
10616 | RBCK1 | P1 | Human | Breast | IDC | 1.87e-12 | -2.14e-02 | 0.1527 |
10616 | RBCK1 | DCIS2 | Human | Breast | DCIS | 1.08e-49 | -7.79e-04 | 0.0085 |
10616 | RBCK1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.88e-09 | 1.41e-01 | 0.0155 |
10616 | RBCK1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 4.02e-02 | 3.22e-01 | -0.1808 |
10616 | RBCK1 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.50e-05 | 3.93e-01 | -0.0811 |
10616 | RBCK1 | HTA11_78_2000001011 | Human | Colorectum | AD | 8.28e-05 | 1.99e-01 | -0.1088 |
10616 | RBCK1 | HTA11_347_2000001011 | Human | Colorectum | AD | 9.54e-16 | 4.82e-01 | -0.1954 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0007249111 | Thyroid | ATC | I-kappaB kinase/NF-kappaB signaling | 135/6293 | 281/18723 | 3.31e-07 | 4.91e-06 | 135 |
GO:005109022 | Thyroid | ATC | regulation of DNA-binding transcription factor activity | 190/6293 | 440/18723 | 1.49e-05 | 1.39e-04 | 190 |
GO:190122421 | Thyroid | ATC | positive regulation of NIK/NF-kappaB signaling | 37/6293 | 69/18723 | 4.80e-04 | 2.81e-03 | 37 |
GO:005109122 | Thyroid | ATC | positive regulation of DNA-binding transcription factor activity | 111/6293 | 260/18723 | 1.32e-03 | 6.88e-03 | 111 |
GO:003806122 | Thyroid | ATC | NIK/NF-kappaB signaling | 64/6293 | 143/18723 | 3.53e-03 | 1.57e-02 | 64 |
GO:190122232 | Thyroid | ATC | regulation of NIK/NF-kappaB signaling | 51/6293 | 112/18723 | 5.68e-03 | 2.30e-02 | 51 |
GO:00434333 | Thyroid | ATC | negative regulation of DNA-binding transcription factor activity | 79/6293 | 185/18723 | 5.96e-03 | 2.40e-02 | 79 |
GO:007026512 | Thyroid | ATC | necrotic cell death | 30/6293 | 62/18723 | 1.12e-02 | 4.00e-02 | 30 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0513124 | Breast | IDC | Shigellosis | 47/867 | 247/8465 | 1.78e-05 | 2.00e-04 | 1.49e-04 | 47 |
hsa0513134 | Breast | IDC | Shigellosis | 47/867 | 247/8465 | 1.78e-05 | 2.00e-04 | 1.49e-04 | 47 |
hsa0513144 | Breast | DCIS | Shigellosis | 46/846 | 247/8465 | 2.06e-05 | 2.38e-04 | 1.75e-04 | 46 |
hsa0513154 | Breast | DCIS | Shigellosis | 46/846 | 247/8465 | 2.06e-05 | 2.38e-04 | 1.75e-04 | 46 |
hsa05131 | Colorectum | AD | Shigellosis | 109/2092 | 247/8465 | 1.09e-11 | 2.44e-10 | 1.55e-10 | 109 |
hsa051311 | Colorectum | AD | Shigellosis | 109/2092 | 247/8465 | 1.09e-11 | 2.44e-10 | 1.55e-10 | 109 |
hsa051312 | Colorectum | SER | Shigellosis | 87/1580 | 247/8465 | 3.07e-10 | 7.27e-09 | 5.28e-09 | 87 |
hsa04217 | Colorectum | SER | Necroptosis | 47/1580 | 159/8465 | 5.21e-04 | 4.44e-03 | 3.22e-03 | 47 |
hsa051313 | Colorectum | SER | Shigellosis | 87/1580 | 247/8465 | 3.07e-10 | 7.27e-09 | 5.28e-09 | 87 |
hsa042171 | Colorectum | SER | Necroptosis | 47/1580 | 159/8465 | 5.21e-04 | 4.44e-03 | 3.22e-03 | 47 |
hsa051314 | Colorectum | MSS | Shigellosis | 94/1875 | 247/8465 | 6.82e-09 | 1.34e-07 | 8.23e-08 | 94 |
hsa051315 | Colorectum | MSS | Shigellosis | 94/1875 | 247/8465 | 6.82e-09 | 1.34e-07 | 8.23e-08 | 94 |
hsa051318 | Colorectum | FAP | Shigellosis | 76/1404 | 247/8465 | 1.57e-08 | 5.84e-07 | 3.55e-07 | 76 |
hsa051319 | Colorectum | FAP | Shigellosis | 76/1404 | 247/8465 | 1.57e-08 | 5.84e-07 | 3.55e-07 | 76 |
hsa0513139 | Esophagus | HGIN | Shigellosis | 71/1383 | 247/8465 | 4.89e-07 | 7.98e-06 | 6.34e-06 | 71 |
hsa046219 | Esophagus | HGIN | NOD-like receptor signaling pathway | 45/1383 | 186/8465 | 3.40e-03 | 2.54e-02 | 2.02e-02 | 45 |
hsa05131114 | Esophagus | HGIN | Shigellosis | 71/1383 | 247/8465 | 4.89e-07 | 7.98e-06 | 6.34e-06 | 71 |
hsa0462114 | Esophagus | HGIN | NOD-like receptor signaling pathway | 45/1383 | 186/8465 | 3.40e-03 | 2.54e-02 | 2.02e-02 | 45 |
hsa05131211 | Esophagus | ESCC | Shigellosis | 176/4205 | 247/8465 | 2.27e-12 | 4.01e-11 | 2.05e-11 | 176 |
hsa0462122 | Esophagus | ESCC | NOD-like receptor signaling pathway | 116/4205 | 186/8465 | 2.90e-04 | 1.03e-03 | 5.30e-04 | 116 |
Page: 1 2 3 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RBCK1 | SNV | Missense_Mutation | novel | c.1515C>G | p.Ser505Arg | p.S505R | Q9BYM8 | protein_coding | tolerated(0.61) | benign(0.022) | TCGA-C5-A1M6-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
RBCK1 | SNV | Missense_Mutation | novel | c.538G>A | p.Glu180Lys | p.E180K | Q9BYM8 | protein_coding | tolerated(0.68) | benign(0.007) | TCGA-C5-A2LZ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Unknown | Unknown | PD |
RBCK1 | SNV | Missense_Mutation | rs752153553 | c.317G>A | p.Arg106Gln | p.R106Q | Q9BYM8 | protein_coding | tolerated(0.34) | benign(0.321) | TCGA-A6-6782-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
RBCK1 | SNV | Missense_Mutation | novel | c.1481G>A | p.Arg494His | p.R494H | Q9BYM8 | protein_coding | deleterious(0) | possibly_damaging(0.644) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
RBCK1 | SNV | Missense_Mutation | c.386N>G | p.Tyr129Cys | p.Y129C | Q9BYM8 | protein_coding | deleterious(0) | possibly_damaging(0.87) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
RBCK1 | SNV | Missense_Mutation | rs139191851 | c.401N>A | p.Arg134His | p.R134H | Q9BYM8 | protein_coding | tolerated(0.62) | benign(0) | TCGA-CM-4746-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
RBCK1 | SNV | Missense_Mutation | c.769C>G | p.Gln257Glu | p.Q257E | Q9BYM8 | protein_coding | tolerated(1) | benign(0) | TCGA-CM-6172-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Ancillary | leucovorin | SD | |
RBCK1 | SNV | Missense_Mutation | c.544N>A | p.Gly182Arg | p.G182R | Q9BYM8 | protein_coding | tolerated(0.51) | benign(0.046) | TCGA-DM-A28C-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
RBCK1 | SNV | Missense_Mutation | novel | c.374N>A | p.Ser125Asn | p.S125N | Q9BYM8 | protein_coding | tolerated(0.21) | benign(0.015) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
RBCK1 | SNV | Missense_Mutation | rs760689114 | c.1292C>T | p.Thr431Met | p.T431M | Q9BYM8 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A5-A0VP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |